The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Asim Amin, Hans Hammers
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019-01-01
Serie:Frontiers in Immunology
Soggetti:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Accesso online:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi